CAS 2378651-62-6 Sucantomotide

Send Inquiry
CAS 2378651-62-6 Sucantomotide
Details
CAS: 2378651-62-6
Sequence: Phe-Met-Leu-Gly-Glu-Phe-Leu-Lys-Leu (FMLGEFLKL)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Tumor Immunopeptide / Adrenal Cancer Vaccine Antigen Peptide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2378651-62-6 sucantomotide in China, also supports custom service. Welcome to wholesale bulk high quality cas 2378651-62-6 sucantomotide from our factory. Contact us for more details.

 

Product name CAS:2378651-62-6:Sucantomotide
Description Sucantomotide is a nonapeptide immunogen derived from tumor-associated antigen, which induces specific cellular immune responses, and is applied in therapeutic vaccine development and tumor immunity mechanism research of adrenocortical carcinoma and other solid tumors.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₅₄H₈₄N₁₀O₁₂S
Molecular weight (Da) 1097.37

 

Products Description

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Sucantomotide Sucantomotide; Adrenal cancer vaccine peptide; CAS 2378651-62-6 Tumor immunogen,Therapeutic vaccine,Adrenocortical carcinoma study,CTL epitope peptide,Cellular immune activation,Solid tumor immunotherapy Phenylalanine-methionine-leucine-glycine-glutamic acid-phenylalanine-leucine-lysine-leucine C₅₄H₈₄N₁₀O₁₂S 1096.6 1097.37 Free amine, no modification Free carboxyl, no modification 9

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-SUC001 white powder Store at -20℃, sealed, dry & protected from light, stored under nitrogen in aliquots; avoid repeated freeze-thaw cycles and strong oxidizing agents Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare aqueous solutions freshly before use Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. **Limited water solubility, small amount of DMSO or dilute acetic acid required for solubilization**. Methionine residue prone to oxidative inactivation, isolate from air and strong oxidizing agents Stable for 3 years at -20℃ under dry, dark & nitrogen atmosphere

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-SUC001 Tumor-associated antigen nonapeptide immunogen that induces specific T cell responses, applied in solid tumor therapeutic vaccine research Sucantomotide is a nonapeptide immunogen screened from solid tumor-associated antigens. It can be processed by antigen-presenting cells and presented via MHC molecules, activating tumor-specific CD4+ helper T cells and CD8+ cytotoxic T lymphocytes, mediating specific killing of tumor cells and inducing long-term immune memory. As the core antigen component of therapeutic vaccines, it shows potential application value in immunotherapy research of refractory solid tumors such as adrenocortical carcinoma. It can also be used in basic research such as tumor immunogenicity verification, T cell activation mechanism analysis and vaccine adjuvant screening, serving as a novel research tool molecule in the field of solid tumor immunotherapy. Adrenocortical carcinoma research,Tumor immunity research,Therapeutic vaccine development,Cellular immunity mechanism study,T cell activation research,Solid tumor immunotherapy Tumor-associated antigen epitope; MHC molecular antigen presentation pathway; CTL-mediated tumor cell killing pathway

Hot Tags: cas 2378651-62-6 sucantomotide, China cas 2378651-62-6 sucantomotide manufacturers, suppliers, factory, 129954-34-3, 2381089-83-2, BPC 157, CAS 121062 08 6, CAS 2381089 83 2, pharmaceutical peptides

Send Inquiry